Paasa Logo
Arcus Biosciences, Inc. logo
RCUSNYSEMarket openCloses 4:00pm ET

Arcus Biosciences, Inc.

$26.31Last updated
+$0.66 (2.57%)Past day
Timezone

Arcus Biosciences, Inc. (NYSE: RCUS) is trading at $26.31, about ₹2,527 at today's USD/INR rate, as of 30 Sep 2026, 12:30 PM ET, up 2.57% today. Indian residents can buy Arcus Biosciences from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$26.18
Previous close:$25.65
Volume:471.67K

Today's low

$25.56

Today's high

$26.35

52 week low

$12.89

52 week high

$31.74

RCUS opened at $26.18, closed previously at $25.65, and has traded between $12.89 and $31.74 over the past 52 weeks.

About

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway, which is in phase 3 and phase 1/1b clinical trial for lung and pancreatic cancer. In addition, the company develops AB598, a CD39 antibody, which is in phase 1/1b clinical study for gastrointestinal cancer and AB801, an AXL inhibitor, which is in Phase 1b clinical trial for lung cancer. It has clinical collaboration with AstraZeneca for the Phase 3 PACIFIC-8 trial evaluating domvanalimab and durvalumab in Stage 3 NSCLC and for a Phase 1/1b study evaluating casdatifan and volrustomig in IO-naive patients with ccRCC and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is based in Hayward, California.

Country
US
CEO
Terry J. Rosen
Exchange listed on
NYSE
Industry
Biotechnology
Base currency
USD
Full Time Employees
601
Sector
Healthcare
IPO date
14/03/2018

Key statistics

Avg. volume

1.37M

Market cap

$3.31B

P/E Ratio

-6.69

Price-to-sales ratio

28.28

Enterprise value

$2.45B

Free cash flow yield

-18.91%

Debt-to-equity ratio

0.25

Return on equity

-55.94%

ROIC

-41.91%

Beta

0.81

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$247.00M

Earnings per share

-$3.29

Free cash flow

-$484.00M

Net profit margin

-386.32%

Gross margin

94.02%

EBITDA

-$335.00M

Revenue growth

-4.26%

Similar securities

This is not an investment recommendation

How to buy Arcus Biosciences from India

Indian residents can buy Arcus Biosciences shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Arcus Biosciences and place an order

    Find Arcus Biosciences by name or by its ticker, RCUS, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Arcus Biosciences trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Arcus Biosciences position in USD and INR. Arcus Biosciences pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Arcus Biosciences from India

Trading and taxes when buying Arcus Biosciences from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneArcus Biosciences does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Arcus Biosciences stock?

Yes. Arcus Biosciences (RCUS) has been listed on the New York Stock Exchange since 2018, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Arcus Biosciences share cost in rupees?

One Arcus Biosciences share is $26.31 — about ₹2,527 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Arcus Biosciences price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Arcus Biosciences from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Arcus Biosciences?

Yes. One Arcus Biosciences share is $26.31, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Arcus Biosciences.

How are gains on Arcus Biosciences shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Arcus Biosciences price. Paasa issues a capital-gains statement for your return.

Does Arcus Biosciences pay a dividend?

No. Arcus Biosciences does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Arcus Biosciences from India?

The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Arcus Biosciences shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Arcus Biosciences shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Arcus Biosciences holding, its cost and its closing value.

How do I sell Arcus Biosciences and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.